Book | 2007
by Arthur A. Daemmrich and Joanna Radin
Perspectives on Risk and Regulation: The FDA at 100 brings together the viewpoints of Food and Drug Administration officials and industry leaders on the future of regulating food, drugs, medical devices, and dietary supplements. In a period of rapid scientific and market changes the success of regulation in these areas increasingly hinges on communication and collaboration between the FDA and the private sector. By situating forward-looking perspectives of agency leaders and industry representatives within FDA’s regulatory history, this volume presents readers with new tools for evaluating policy recommendations and will better equip the public and experts to assess pressing regulatory issues.
http://people.hbs.edu/adaemmrich/FDAfinal.pdf
Keywords: Private Sector; Governing Rules, Regulations, and Reforms; Policy; Health Care and Treatment; Business and Government Relations; Risk and Uncertainty; Cooperation;
Citation:
Daemmrich, Arthur A., and Joanna Radin, eds. Perspectives on Risk and Regulation: The FDA at 100. Chemical Heritage Foundation, 2007. (Fulltext.)
View Profile »View Publications »
Case | HBS Case Collection | 2012 (Revised from original 2012 version)
Telecommunications Regulation and Coordinated Competition in Romania
Arthur Daemmrich, Alex Radu and Ana Sarbu
Keywords: regulation; Auction Policy; European Union; government policy; cell phone industry; Mergers and Acquisitions; Telecommunications Industry; Romania;
Teaching Note | HBS Case Collection | 2012
Telecommunications Regulation and Coordinated Competition in Romania (TN)
Arthur A. Daemmrich
GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships (TN)